Patient Management

2074 questions

Question 1441Question →

A 73-year-old man presents to the clinic for a health maintenance visit. He has not seen a healthcare provider in over a decade. His medical history is significant for ischemic cardiomyopathy with a left ventricular ejection fraction of 25%, New York Heart Association class III heart failure, and severe chronic obstructive pulmonary disease requiring continuous home oxygen therapy. He is a current smoker with a 55 pack-year smoking history. The patient spends the majority of his day resting in a recliner due to dyspnea on minimal exertion. His medications include aspirin, metoprolol succinate, sacubitril-valsartan, empagliflozin, furosemide, and a fluticasone-umeclidinium-vilanterol inhaler.

He has never undergone screening for colon, prostate, or lung cancer. He recently read an article about the importance of early cancer detection and asks which screening tests he should undergo today.

Which of the following is the most appropriate recommendation regarding cancer screening for this patient?

Show answer & explanation

Answer: Advise against routine cancer screening

Answer

The most appropriate recommendation is to advise against routine cancer screening due to the patient's severely limited life expectancy and high operative risk.
The correct recommendation is to advise against routine cancer screening. Although this patient meets the strict age and risk factor criteria for both lung and colorectal cancer screening, the foundational principle of preventive care requires that a patient have a sufficient life expectancy to realize a benefit. The mortality benefit of colorectal cancer screening takes approximately 10 years to accrue; thus, the United States Preventive Services Task Force (USPSTF) recommends against screening in patients with a life expectancy of less than 10 years. Furthermore, USPSTF guidelines explicitly state that lung cancer screening with low-dose computed tomography should be discontinued if a health problem substantially limits life expectancy or the ability to have curative lung surgery. This patient's severe ischemic cardiomyopathy and oxygen-dependent COPD severely limit his life expectancy and make him a prohibitive surgical risk, rendering all cancer screening inappropriate.

Step-by-Step Solution

1
Evaluate the patient's baseline eligibility for cancer screening based on age and risk factors.
The patient is 73 years old with a 55 pack-year smoking history, which traditionally qualifies him for lung (LDCT) and colorectal cancer screening under standard guidelines.
Identifying baseline age and risk-factor eligibility is the necessary first step before applying clinical modifiers.
2
Assess the patient's overall health status, life expectancy, and ability to undergo definitive treatment if cancer is found.
The patient has end-stage cardiopulmonary disease (LVEF 25%, NYHA III HF, COPD on continuous oxygen). His life expectancy is likely less than 5 years, and he is not a candidate for major surgical interventions like lung resection or colectomy.
Preventive screening is only beneficial if the patient will live long enough to realize the mortality benefit and is well enough to tolerate the required treatments.
3
Apply guideline-specific exclusion criteria to the identified screening tests.
Guidelines explicitly state to discontinue colorectal cancer screening if life expectancy is < 10 years, and to discontinue lung cancer screening if the patient cannot have curative lung surgery. Therefore, screening should be withheld.
Recommending screening in this scenario exposes the patient to the immediate harms and anxieties of testing without any plausible long-term benefit.

Key Concept

Cancer screening must be discontinued in patients with a substantially limited life expectancy (e.g., < 10 years for colorectal cancer) or those who are not candidates for curative surgical interventions due to severe comorbid conditions.
Estimated Time:1m 15s
Question 1442Question →

Seeking to establish care after recently relocating, a 68-year-old woman presents to a new primary care provider for a wellness visit. Her past medical history is notable for human immunodeficiency virus (HIV) infection, diagnosed two decades ago, which remains well-controlled on a daily antiretroviral regimen. Her most recent CD4 T-lymphocyte count is 680 cells/mm³, and her viral load is undetectable. She smoked one pack of cigarettes daily from age 20 to age 38, completely abstaining since then.

A review of her previous medical records reveals the following preventive care history:
- A screening colonoscopy at age 60 demonstrated no polyps or masses.
- A screening mammogram performed 11 months ago was interpreted as Breast Imaging Reporting and Data System (BI-RADS) category 1.
- A dual-energy x-ray absorptiometry scan at age 65 showed a T-score of -0.8 at the lumbar spine and femoral neck.
- Cervical cancer screening via cytology and high-risk human papillomavirus (hrHPV) co-testing was performed at ages 59, 62, and 65; all results were negative for intraepithelial lesion or malignancy and negative for hrHPV.

The patient currently takes no medications other than her antiretroviral therapy. She is up to date on her recombinant zoster vaccine, pneumococcal vaccination series, and the seasonal influenza vaccine.

Based on current evidence-based guidelines, which of the following screening tests is indicated for this patient today?

Show answer & explanation

Answer: Cervical cytology and high-risk human papillomavirus co-testing

Answer

Cervical cytology and high-risk human papillomavirus co-testing
The correct answer is to perform cervical cytology and high-risk human papillomavirus co-testing. In the general population, cervical cancer screening can be discontinued at age 65 if the patient has had adequate prior negative screening (e.g., three consecutive negative cytology results or two consecutive negative co-tests within the past 10 years). However, there are critical exceptions to this rule. Women who are infected with HIV, have a history of in utero diethylstilbestrol (DES) exposure, or have a history of cervical cancer or high-grade cervical dysplasia (CIN 2/3) must continue cervical cancer screening throughout their lifetime. For women with HIV who have had three consecutive normal annual cytology tests, the recommended screening interval becomes every 3 years. Because this patient's last co-test was at age 65, she is exactly due for her next screening at age 68.

Step-by-Step Solution

1
Evaluate the patient's demographic and clinical risk profile.
The patient is a 68-year-old female with HIV and an 18 pack-year smoking history (quit 30 years ago).
Age, biological sex, smoking history, and immune status directly dictate preventive screening eligibility.
2
Assess eligibility for lung, colon, breast, and bone density screening based on recent test dates.
Lung: ineligible (quit >15 years ago, <20 pack-years). Colon: due at 70. Breast: due next year (biennial). Bone: normal at 65, no repeat needed yet.
Avoids premature or contraindicated testing.
3
Apply cervical cancer screening guidelines for special populations.
While average-risk women stop screening at 65 after adequate negative results, HIV-positive women require lifelong screening.
HIV-associated immunodeficiency alters the natural history of HPV infection, maintaining a lifelong risk for cervical dysplasia.
4
Determine the appropriate interval for the indicated test.
The patient's last negative co-test was at age 65 (3 years ago), making her due for her next 3-year interval screening today.
Routine interval for HIV-positive women over age 30 with at least 3 consecutive normal annual Paps is every 3 years.

Key Concept

Cervical cancer screening exceptions (Lifelong screening in HIV)
Question 1443Question →

A 54-year-old man is brought to the emergency department due to sudden onset of severe, "tearing" chest pain that radiates to his interscapular region. The pain started 45 minutes ago while he was moving heavy furniture. He has a history of essential hypertension and tobacco use. On presentation, he is anxious and diaphoretic. Vital signs are temperature 37.0°C (98.6°F), blood pressure 210/120 mmHg in the right arm and 170/100 mmHg in the left arm, heart rate 115/min, and respiratory rate 24/min. Pulse oximetry is 96% on room air. Neurologic examination is unremarkable. Electrocardiogram reveals sinus tachycardia with left ventricular hypertrophy but no acute ischemic changes. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Administration of intravenous esmolol

Answer

The correct answer is the administration of intravenous esmolol.
In a patient with a highly suspected acute aortic dissection (tearing chest/back pain, asymmetric blood pressures), immediate medical management focuses on anti-impulse therapy to reduce aortic wall shear stress (dP/dt). Intravenous beta-blockers (such as esmolol or labetalol) are the first-line agents to rapidly lower both heart rate and blood pressure before sending the patient for definitive diagnostic imaging.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and vital signs.
The patient has severe, tearing chest pain radiating to the back, severe hypertension, and asymmetric blood pressures in the upper extremities.
To form a primary working diagnosis of acute aortic dissection.
2
Determine the most critical initial management priority for the suspected diagnosis.
The immediate goal is anti-impulse therapy to reduce left ventricular contractility (dP/dt) and sheer stress on the aortic wall.
To prevent rapid propagation of the intimal tear, which can lead to fatal complications such as rupture or tamponade.
3
Select the appropriate pharmacologic agent for initial stabilization.
An intravenous beta-blocker, such as esmolol or labetalol, is selected to rapidly lower the heart rate (goal < 60/min) and blood pressure.
Beta-blockade must always precede vasodilation (e.g., nitroprusside) in this context to prevent reflex tachycardia.

Key Concept

Prioritizing anti-impulse therapy (beta-blockade) for hemodynamic stabilization in acute aortic dissection before proceeding with definitive diagnostic imaging.
Question 1444Question →

During a routine health maintenance visit, a 58-year-old male with essential hypertension and chronic kidney disease stage 2 is prescribed lisinopril. His blood pressure in the clinic is 152/94 mmHg. Baseline laboratory studies obtained today show a serum creatinine of 1.2 mg/dL and a serum potassium of 4.3 mEq/L. The patient is instructed on how to take the medication and asked to schedule a follow-up visit. Which of the following is the most appropriate next step in monitoring this patient's new therapy?

Show answer & explanation

Answer: Assess serum creatinine and potassium levels in 1 to 2 weeks

Answer

Assess serum creatinine and potassium levels in 1 to 2 weeks
ACE inhibitors (such as lisinopril) reduce angiotensin II levels, leading to vasodilation of the efferent arteriole in the glomerulus. While this offers long-term renal protection, it can cause an acute, transient drop in the glomerular filtration rate (GFR) and a subsequent rise in serum creatinine. Furthermore, the resulting decrease in aldosterone production can lead to potassium retention. Therefore, standard medical guidelines require rechecking serum creatinine and potassium 1 to 2 weeks after initiating or increasing the dose of an ACE inhibitor or angiotensin receptor blocker (ARB). An asymptomatic increase in creatinine of up to 30% is generally acceptable, but larger increases or severe hyperkalemia may necessitate discontinuing the drug.

Step-by-Step Solution

1
Identify the newly prescribed medication and its mechanism of action.
The patient is starting lisinopril, an angiotensin-converting enzyme (ACE) inhibitor.
Understanding the drug class is necessary to anticipate potential adverse physiologic effects.
2
Determine the standard monitoring guidelines for this specific medication class.
Guidelines recommend checking renal function and serum potassium within 1 to 2 weeks after initiation or dose adjustment.
ACE inhibitors dilate the efferent arteriole, which can cause an acute decline in glomerular filtration rate (GFR). They also decrease aldosterone production, leading to potassium retention.

Key Concept

ACE inhibitors require monitoring of a basic metabolic panel (specifically serum creatinine and potassium) within 1 to 2 weeks of initiation or dose titration to evaluate for acute kidney injury and hyperkalemia.
Question 1445Question →

A 78-year-old man is evaluated in the intensive care unit for right upper quadrant abdominal pain and fever. Three days ago, he was admitted for an acute anterior ST-elevation myocardial infarction complicated by cardiogenic shock. He was treated with primary percutaneous coronary intervention and placement of a drug-eluting stent. His current medications include aspirin, ticagrelor, high-intensity statin, and a continuous intravenous infusion of norepinephrine.

His temperature is 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}), blood pressure is 88/54 mm Hg88/54\text{ mm Hg}, pulse is 112/min112/\text{min}, and respiratory rate is 22/min22/\text{min}. Physical examination reveals marked right upper quadrant tenderness with guarding. A bedside ultrasound demonstrates a distended gallbladder with a thickened wall measuring 8 mm8\text{ mm}, pericholecystic fluid, and multiple echogenic gallstones. The common bile duct diameter is 5 mm5\text{ mm} with no stones visualized within it. Laboratory studies show a leukocyte count of 19,500/μL19,500/\mu\text{L}, total bilirubin of 0.9 mg/dL0.9\text{ mg/dL}, and alkaline phosphatase of 110 U/L110\text{ U/L}. Intravenous fluid resuscitation and broad-spectrum antibiotics have been initiated.

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Percutaneous cholecystostomy tube placement

Answer

Percutaneous cholecystostomy tube placement is the most appropriate intervention.
The patient presents with classic signs of acute cholecystitis, complicated by sepsis and hemodynamic instability. The definitive treatment for acute cholecystitis is typically surgical removal of the gallbladder (cholecystectomy). However, this patient is a prohibitively high surgical risk due to his recent severe anterior myocardial infarction, cardiogenic shock requiring norepinephrine, and strict requirement for dual antiplatelet therapy to prevent coronary stent thrombosis. In critically ill patients who are unfit for surgery, percutaneous cholecystostomy tube placement under ultrasound or computed tomography guidance is the most appropriate next step. It provides immediate biliary decompression and source control without the physiological stress of general anesthesia or major surgery.

Step-by-Step Solution

1
Diagnose the acute condition based on clinical and ultrasound findings.
The patient has severe acute calculous cholecystitis complicated by sepsis.
Fever, right upper quadrant pain, leukocytosis, and classic sonographic signs (wall thickening, pericholecystic fluid, gallstones) confirm the diagnosis.
2
Evaluate the patient's surgical risk.
The patient is deemed a prohibitively high-risk surgical candidate.
Recent severe myocardial infarction, ongoing cardiogenic shock requiring vasopressors, and absolute necessity for uninterrupted dual antiplatelet therapy make general anesthesia and surgery unsafe.
3
Select the optimal therapeutic intervention for an unstable, poor surgical candidate.
Percutaneous cholecystostomy tube placement is indicated.
When cholecystectomy is contraindicated, percutaneous drainage decompresses the gallbladder, provides necessary source control, and stabilizes the patient until they may become a surgical candidate in the future.

Key Concept

In critically ill patients with acute cholecystitis who are poor surgical candidates, percutaneous cholecystostomy tube placement is the preferred intervention for gallbladder decompression and source control.
Estimated Time:1m 30s
Question 1446Question →

Following an open reduction and internal fixation for a comminuted right tibial diaphysis fracture, a young adult patient is evaluated on the surgical ward for intractable lower extremity pain. The operative procedure was completed 14 hours ago. The overnight nursing staff reports that the patient has required multiple breakthrough doses of intravenous hydromorphone with minimal relief.

The patient describes the pain as a severe, deep burning sensation in the right calf that is significantly worse than his preoperative pain. On physical examination, the right leg is markedly swollen, and the anterior compartment feels exceptionally tight and woody to palpation. Passive plantar flexion of the right ankle elicits agonizing pain. Dorsalis pedis and posterior tibial pulses are 2+ and symmetric with the left foot. Capillary refill is less than 2 seconds in the right toes, but the patient reports decreased sensation to light touch in the first dorsal web space. All compressive dressings and bandages have already been completely removed down to the skin, with no improvement in symptoms.

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Immediate multi-compartment fasciotomy

Answer

Immediate multi-compartment fasciotomy
The correct answer is immediate multi-compartment fasciotomy. The patient presents with textbook signs of acute compartment syndrome (ACS) of the anterior compartment of the lower leg: severe pain out of proportion to the injury, pain with passive stretch (plantar flexion), tense/woody swelling, and paresthesias in the distribution of the deep peroneal nerve (first dorsal web space). Because the clinical diagnosis is unequivocal and the initial non-surgical step of removing all constrictive dressings has already been completed, emergent surgical decompression via fasciotomy is definitively indicated to prevent irreversible tissue necrosis.

Step-by-Step Solution

1
Recognize the clinical signs of acute compartment syndrome (ACS).
The patient has pain out of proportion to the injury, severe pain on passive stretch of the affected muscles (plantar flexion stretches the anterior compartment), woody tissue tension, and early neurological deficits (decreased sensation in the first web space via the deep peroneal nerve).
These classic indicators strongly point to ACS. Notably, bounding pedal pulses remain present because compartmental pressure rarely exceeds systolic arterial pressure, meaning pulselessness is a very late and often irreversible sign.
2
Determine the necessity of diagnostic testing versus immediate intervention.
Because the clinical diagnosis is unambiguous and all restrictive dressings have already been removed, immediate surgical intervention is indicated without further confirmatory testing.
Delaying treatment to measure intracompartmental pressures in a clinically obvious case increases the risk of irreversible ischemic muscle contracture and nerve necrosis.
3
Select the definitive management step.
A multi-compartment fasciotomy is required immediately.
Fasciotomy is the definitive treatment, as it immediately relieves the elevated intracompartmental pressure and restores microvascular perfusion to the affected tissues.

Key Concept

In patients with unequivocal clinical signs of acute compartment syndrome (pain out of proportion, pain on passive stretch, woody induration, paresthesias), immediate fasciotomy is the treatment of choice and should not be delayed for compartment pressure measurements.
Question 1447Question →

A 63-year-old man presents to the clinic for a routine wellness evaluation. His medical history includes type 2 diabetes mellitus, hyperlipidemia, and mild osteoarthritis. He smoked one pack of cigarettes daily for 25 years but successfully quit at age 45. His family history is non-contributory.

Review of his preventive care records reveals the following:
- A screening colonoscopy performed at age 58 showed three 6-mm tubular adenomas, which were completely excised.
- He received the 20-valent pneumococcal conjugate vaccine (PCV20) at age 58 shortly after his diabetes diagnosis.
- He received a 2-dose series of recombinant zoster vaccine at age 50.
- He received a tetanus-diphtheria-acellular pertussis (Tdap) booster 4 years ago.
- He has never undergone abdominal imaging.

He currently has no symptoms, and his diabetes is well-controlled. Which of the following is the most appropriate next step in this patient's preventive care?

Show answer & explanation

Answer: Repeat colonoscopy

Answer

Repeat colonoscopy
The patient requires a surveillance colonoscopy. According to the US Multi-Society Task Force (USMSTF) on Colorectal Cancer, a baseline finding of 3 to 4 small (<10 mm) tubular adenomas warrants a repeat surveillance colonoscopy in 3 to 5 years. Because his last procedure was 5 years ago, he has reached the end of this interval and is currently due for a repeat procedure.

Step-by-Step Solution

1
Analyze the patient's colorectal cancer surveillance requirements based on prior colonoscopy findings.
The patient had three small (<10 mm) tubular adenomas at age 58. Per the US Multi-Society Task Force (USMSTF), the recommended interval is 3 to 5 years.
Different baseline polyp burdens mandate different direct visualization intervals to prevent colorectal cancer.
2
Evaluate the patient's eligibility for lung cancer screening.
The patient is 63 with a 25 pack-year history, but he quit 18 years ago (at age 45). He exceeds the 15-year cessation limit, so screening is no longer indicated.
USPSTF LDCT guidelines (age 50-80, ≥20 pack-years) strictly require the patient to be a current smoker or have quit within the past 15 years.
3
Assess the need for abdominal aortic aneurysm (AAA) screening.
The patient is 63 years old. AAA screening is not indicated until age 65.
USPSTF recommends one-time AAA screening with ultrasound for men aged 65 to 75 who have ever smoked.
4
Review the patient's immunization status.
He received Tdap 4 years ago (not due for 6 years). He received a complete RZV series. He received PCV20 at age 58 and therefore requires no further pneumococcal doses (PPSV23 is unnecessary).
Recent ACIP guidelines simplified pneumococcal schedules; a single dose of PCV20 is considered a complete series for adults.

Key Concept

Evidence-based application of multiple concurrent preventive screening and immunization guidelines (USPSTF, USMSTF, ACIP) with a focus on specific interval cutoffs and contraindications.
Estimated Time:2m 0s
Question 1448Question →

A 52-year-old man visits the clinic for a follow-up appointment. He has a history of chronic hepatitis C virus (HCV) infection, genotype 1a. He has just taken the final dose of a 12-week regimen of daily glecaprevir-pibrentasvir. Prior to initiating therapy, baseline testing for hepatitis B virus and HIV was negative, and liver transient elastography demonstrated a fibrosis score of F2 (moderate fibrosis). The patient reports feeling well and has experienced no adverse effects from the medication. He has no history of alcohol use disorder. Physical examination shows no jaundice, spider angiomata, or hepatosplenomegaly.

Serial laboratory results are as follows:

ParameterBaseline (Day 0)Week 4Today (Week 12)
ALT78 U/L22 U/L19 U/L
AST65 U/L18 U/L16 U/L
Total bilirubin0.9 mg/dL0.8 mg/dL0.7 mg/dL
HCV RNA2.4×1062.4 \times 10^6 IU/mLNot measuredNot measured

The patient asks how the clinical team will determine if his liver infection has been fully cured by the antiviral regimen. Which of the following is the most appropriate next step in evaluating the success of this patient's treatment?

Show answer & explanation

Answer: Measure serum HCV RNA level 12 weeks from today

Answer

Measure serum HCV RNA level 12 weeks from today.
The defining metric of treatment success for chronic hepatitis C virus (HCV) infection is the achievement of a sustained virologic response (SVR). SVR is defined as an undetectable serum HCV RNA viral load at least 12 weeks after the completion of a direct-acting antiviral (DAA) regimen (SVR12). Achieving SVR12 corresponds to a virologic cure in greater than 95% of patients. Therefore, instructing the patient to return for a serum HCV RNA test 12 weeks from today is the most appropriate next step in his management.

Step-by-Step Solution

1
Analyze the patient's current clinical status and treatment phase.
The patient is a 52-year-old man with F2 fibrosis who has just completed a 12-week course of direct-acting antiviral (DAA) therapy for chronic HCV.
Understanding the patient's fibrosis stage and treatment timeline is required to apply the correct post-treatment monitoring guidelines.
2
Determine the gold standard for defining HCV treatment success.
Cure is defined clinically as a sustained virologic response (SVR).
SVR indicates that the virus has been completely eradicated from the body and will not rebound.
3
Identify the proper timing and modality to confirm SVR.
SVR is confirmed by obtaining an undetectable serum HCV RNA level at least 12 weeks after the final dose of DAA therapy (SVR12).
Testing before 12 weeks post-treatment (such as end-of-treatment testing) does not predict long-term eradication and is no longer recommended by current guidelines.
4
Evaluate the need for long-term complication screening based on baseline fibrosis.
The patient has F2 fibrosis, which does not meet the threshold for hepatocellular carcinoma (HCC) screening.
HCC surveillance (via ultrasound every 6 months) is strictly reserved for patients with advanced fibrosis (F3) or cirrhosis (F4).

Key Concept

Monitoring and Treatment Evaluation for Chronic Hepatitis C
Estimated Time:1m 30s
Question 1449Question →

Five patients are currently awaiting transition from an acute care hospital. The attending physician must determine the correct post-acute environment for each based on their current clinical stability, rehabilitation tolerance, and functional deficits. Match each patient scenario with the most appropriate post-acute care setting.

Click a left item, then click its matching right item

Items

55-year-old man recovering from Guillain-Barré syndrome; medically stable but requires intensive physical, occupational, and speech therapy and can actively participate for at least 3 hours daily.
65-year-old woman status-post prolonged ICU stay for sepsis; requires mechanical ventilation weaning via tracheostomy and daily complex surgical wound debridement.
82-year-old man post-operative day 4 for a hip fracture; requires daily physical therapy but fatigues after 30-45 minutes, and needs completion of a 10-day course of intravenous antibiotics.
89-year-old woman with advanced dementia; bedbound, totally dependent for all basic activities of daily living (ADLs), requires continuous supervision but no active skilled medical interventions.
78-year-old man with mild cognitive impairment; independently ambulatory and continent, but unable to safely manage medications, cook, or handle finances; family is unavailable to assist.

Matches

Show answer & explanation

Answer

The correct matches align patients with strict admission criteria: intense rehab tolerance matches Acute Rehab; prolonged critical medical needs matches LTAC; skilled care with low rehab tolerance matches Subacute/Skilled Nursing; basic ADL dependence without skilled needs matches Custodial Care; and IADL dependence only matches Assisted Living.
Each patient's clinical presentation precisely matches the regulatory and clinical admission criteria for the respective facilities. Acute Rehab requires 3 hours of daily therapy; LTACs handle prolonged ventilation and complex medical needs; Subacute Care provides skilled interventions and low-intensity rehab; Custodial Care supports severe ADL deficits without skilled needs; and Assisted Living supports IADL deficits in patients independent with basic ADLs.

Step-by-Step Solution

1
Assess the patient's medical stability and need for ongoing skilled medical interventions.
Identifies if the patient needs hospital-level care (LTAC), skilled care, or non-skilled supervision.
The fundamental level of medical acuity determines the baseline facility tier required for safe disposition.
2
Evaluate the patient's functional status and physical tolerance for active rehabilitation.
Differentiates between Acute Rehab (must tolerate >3 hours/day of therapy) and Subacute Rehab (appropriate for less intensive therapy tolerance).
Medicare and insurance guidelines strictly dictate admission criteria for rehabilitation facilities based on the patient's ability to actively participate in therapy.
3
Differentiate between deficits in basic Activities of Daily Living (ADLs) versus Instrumental Activities of Daily Living (IADLs).
Distinguishes between Custodial Care (needs help with basic ADLs like bathing, feeding, transferring) and Assisted Living (needs help with IADLs like medications, finances, meal prep).
Accurately matching the care setting to the specific functional deficit prevents unnecessary healthcare utilization and ensures patient safety.

Key Concept

Discharge planning requires matching a patient's medical acuity, skilled care requirements, rehabilitation tolerance, and functional deficits (ADLs vs. IADLs) to specific facility admission criteria.
Question 1450Question →

Match each patient's clinical presentation with the most appropriate next step in their diagnostic workup and test sequencing, according to established guidelines for pulmonary nodules and lung mass evaluation.

Click a left item, then click its matching right item

Items

68-year-old current smoker with an incidentally discovered 12-mm solid pulmonary nodule; no prior imaging available.
42-year-old never-smoker with a 4-mm solid pulmonary nodule found on a chest CT performed for blunt chest trauma.
58-year-old former smoker with a 7-mm solid pulmonary nodule; a previous chest CT from 36 months ago demonstrates an identical 7-mm nodule in the exact same location.
72-year-old current smoker with a 3.5-cm lung mass and enlarged ipsilateral paratracheal lymph nodes; PET-CT shows avid uptake in both the mass and the nodes.
55-year-old current smoker with an incidentally discovered 9-mm pure ground-glass (subsolid) pulmonary nodule; no prior imaging available.

Matches

Show answer & explanation

Answer

The 12-mm solid nodule matches with PET-CT. The 4-mm solid nodule in a low-risk patient requires no routine follow-up. The 7-mm solid nodule stable for 36 months requires discontinuation of surveillance. The PET-avid mediastinal nodes require tissue confirmation via EBUS-TBNA. The 9-mm pure ground-glass nodule requires a follow-up CT in 6 to 12 months.
Diagnostic sequencing for pulmonary abnormalities requires integrating nodule characteristics with staging algorithms. Solid nodules >8 mm require functional imaging (PET-CT). Solid nodules <6 mm in low-risk individuals require no follow-up to minimize unnecessary radiation. Solid nodules stable for >24 months are considered benign, warranting definitive discontinuation of surveillance. Pure ground-glass nodules >6 mm behave indolently and require delayed follow-up at 6-12 months rather than immediate PET-CT. Finally, during clinical staging, PET-avid lymph nodes must always be tissue-sampled (e.g., via EBUS-TBNA) to rule out inflammatory false-positives before determining surgical candidacy.

Step-by-Step Solution

1
Analyze the 68-year-old smoker with a 12-mm nodule.
Identify this as a high-risk solid nodule >8 mm.
Guidelines require PET-CT for functional assessment and staging before biopsy for large solid nodules in high-risk patients.
2
Analyze the 42-year-old never-smoker with a 4-mm nodule.
Identify this as a low-risk solid nodule <6 mm.
Low-risk micro-nodules have negligible malignancy risk and require no follow-up.
3
Analyze the 58-year-old with a 7-mm nodule stable for 36 months.
Determine the nodule is benign based on temporal stability.
Solid nodules stable for >24 months do not require further imaging surveillance.
4
Analyze the 72-year-old with a mass and PET-avid mediastinal nodes.
Identify the need for tissue sampling of the mediastinum.
PET-avid nodes can be falsely positive; pathological confirmation of N2 disease via EBUS-TBNA is mandatory before determining treatment pathways.
5
Analyze the 55-year-old with a 9-mm pure ground-glass nodule.
Select delayed CT follow-up at 6-12 months.
Pure GGOs behave indolently compared to solid nodules and do not warrant immediate PET-CT, even if >8 mm.

Key Concept

Pulmonary nodule evaluation and lung mass test sequencing relies heavily on nodule size, composition (solid vs. subsolid), patient risk factors, temporal stability, and the necessity of tissue confirmation for metabolically active nodes.
Estimated Time:2m 30s
Question 1451Question →

Emergency medical services bring a 72-year-old woman to the acute care bay because she suddenly developed right-sided weakness, right facial droop, and severe expressive aphasia exactly 45 minutes prior to arrival. Her current blood pressure is 175/95 mmHg, and her heart rate is 92/min with an irregularly irregular rhythm. Medical records indicate a history of hypertension and atrial fibrillation, for which she recently stopped taking her anticoagulant medication. The clinical presentation is highly suspicious for an acute ischemic stroke. Which of the following are the most critical initial diagnostic tests that should be ordered immediately to determine her eligibility for acute pharmacological reperfusion therapy? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Non-contrast computed tomography (CT) scan of the head; Point-of-care blood glucose measurement

Answer

The most critical initial diagnostic tests are a non-contrast CT scan of the head and a point-of-care blood glucose measurement.
In a patient presenting with hyperacute focal neurologic deficits within the thrombolytic time window, the immediate priority is to determine eligibility for pharmacological reperfusion. The absolute minimum diagnostic tests required before administration are a non-contrast head CT (to definitively rule out intracranial hemorrhage) and a point-of-care blood glucose measurement (to rule out profound hypoglycemia, which is a common, easily reversible stroke mimic). Other tests should not delay these critical, time-sensitive steps.

Step-by-Step Solution

1
Identify the hyperacute presentation of focal neurologic deficits
The patient is within the standard 4.5-hour time window for intravenous thrombolytic therapy.
Establishing the timeline determines the urgency and specific pathway of diagnostic testing.
2
Select imaging to rule out absolute contraindications to thrombolytics
Non-contrast head CT is chosen.
It rapidly and definitively rules out intracranial hemorrhage, which strictly contraindicates the use of tissue plasminogen activator (tPA).
3
Select laboratory testing to rule out common stroke mimics
Point-of-care blood glucose is chosen.
Severe hypoglycemia must be excluded immediately, as it can present with identical focal symptoms and requires completely different management.

Key Concept

The immediate evaluation of a suspected acute stroke requires a non-contrast head CT to rule out hemorrhage and a blood glucose check to rule out hypoglycemia before administering any reperfusion therapy.
Question 1452Question →

A 29-year-old woman, gravida 2, para 1, at 26 weeks gestation, comes to the emergency department due to sudden-onset shortness of breath and sharp, right-sided chest pain that worsens with deep inspiration. The symptoms began 2 hours ago. She also reports progressive swelling and discomfort in her left leg over the past 3 days. Her pregnancy has been uncomplicated, and she has no significant past medical history. She takes prenatal vitamins. Her temperature is 37.1 C (98.8 F), blood pressure is 112/70 mm Hg, pulse is 118/min, and respirations are 24/min. Pulse oximetry shows 94% on room air. Examination reveals clear lungs bilaterally. The cardiovascular examination is notable for tachycardia without murmurs. The left calf is visibly swollen, erythematous, and tender to palpation, with a circumference 4 cm greater than the right calf. Which of the following is the most appropriate next step in the diagnostic evaluation of this patient?

Show answer & explanation

Answer: Compression ultrasonography of the lower extremities

Answer

Compression ultrasonography of the lower extremities
The correct answer is compression ultrasonography of the lower extremities. In pregnant patients who present with signs and symptoms of both pulmonary embolism and deep vein thrombosis, the safest and most appropriate initial diagnostic step is to evaluate the symptomatic leg with ultrasound. Confirming a deep vein thrombosis provides a definitive indication to initiate therapeutic anticoagulation, which is the exact same treatment required for a pulmonary embolism. This step-wise approach prevents the mother and fetus from being exposed to the ionizing radiation associated with chest radiography, computed tomography, or ventilation-perfusion scanning.

Step-by-Step Solution

1
Evaluate the clinical presentation and vital signs.
The patient presents with tachycardia, tachypnea, hypoxia, pleuritic chest pain, and a unilaterally swollen, tender leg.
To establish a high clinical suspicion for acute pulmonary embolism and concurrent deep vein thrombosis.
2
Consider the diagnostic constraints unique to this patient.
The patient is in her second trimester of pregnancy, meaning diagnostic algorithms must prioritize minimizing radiation exposure to the fetus.
To apply principles of radiation stewardship and patient safety.
3
Determine the optimal diagnostic sequence according to guidelines.
Guidelines dictate that pregnant patients with suspected pulmonary embolism and symptoms of deep vein thrombosis should first undergo compression ultrasonography of the symptomatic leg.
If the ultrasound is positive, therapeutic anticoagulation is initiated (which treats both conditions), safely avoiding the need for thoracic imaging such as CT or V/Q scan.

Key Concept

In pregnant patients with suspected pulmonary embolism and concurrent symptoms of deep vein thrombosis, bilateral or symptomatic-leg compression ultrasonography is the preferred initial diagnostic test to potentially avoid fetal radiation exposure.
Estimated Time:1m 0s
Question 1453Question →

A 5252-year-old woman is brought to the emergency department by her husband due to the sudden onset of an excruciating headache that began 8 hours8\text{ hours} ago. She describes it as the "worst headache of my life" and reports one episode of vomiting and extreme sensitivity to room lights. Her medical history is significant for a mechanical mitral valve replacement performed 3 years3\text{ years} ago for severe rheumatic mitral stenosis. Her daily medications include warfarin and metoprolol.

On presentation, her temperature is 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}), blood pressure is 168/94 mm Hg168/94\text{ mm Hg}, pulse is 88/min88/\text{min}, and respiratory rate is 16/min16/\text{min}. Neurologic examination reveals a fully alert and oriented patient with intact cranial nerves, normal motor strength, and normal sensory function. Mild nuchal rigidity is present.

Laboratory studies show an international normalized ratio (INR) of 3.23.2.

A non-contrast computed tomography (CT) scan of the head is performed and reveals no acute intracranial hemorrhage, mass effect, or midline shift.

Which of the following is the most appropriate next step in the diagnostic workup?

Show answer & explanation

Answer: Computed tomography angiography of the head

Answer

Computed tomography angiography of the head is the correct next step because lumbar puncture is strictly contraindicated due to the patient's supratherapeutic INR, and reversing anticoagulation in a patient with a mechanical heart valve poses an unacceptably high risk of fatal thrombosis.
The correct answer represents the optimal adaptation of a standard diagnostic algorithm to a complex patient scenario. In suspected subarachnoid hemorrhage (SAH), a non-contrast CT is the initial test. Because CT sensitivity drops over time, a negative scan must be followed by a lumbar puncture (LP) to assess for red blood cells and xanthochromia. However, this patient has an INR of 3.2 due to warfarin therapy for a mechanical mitral valve. Performing an LP in the setting of therapeutic anticoagulation is strictly contraindicated due to the high risk of iatrogenic spinal epidural hematoma. Furthermore, reversing the patient's anticoagulation with prothrombin complex concentrate to perform the LP would place her at immediate and unacceptable risk for mechanical valve thrombosis and catastrophic embolic stroke. Therefore, the safest and most appropriate next step in the diagnostic workup is to bypass the LP and perform computed tomography angiography (CTA) of the head. CTA is a rapid, non-invasive modality with high sensitivity for detecting ruptured intracranial aneurysms, serving as an effective surrogate diagnostic step when LP cannot be safely executed.

Step-by-Step Solution

1
Identify the primary clinical syndrome.
The patient has a thunderclap headache with meningismus, which is highly suspicious for acute subarachnoid hemorrhage (SAH).
This establishes the need to rapidly confirm or rule out an intracranial bleed to prevent catastrophic re-bleeding.
2
Evaluate the results of the initial standard diagnostic test.
The non-contrast CT of the head is negative.
CT is highly sensitive for SAH within the first few hours but can be falsely negative in up to 10% of cases as time elapses (e.g., 8 hours after onset).
3
Determine the standard sequential next step and assess for contraindications.
Lumbar puncture (LP) is the standard next step to check for xanthochromia, but the patient's therapeutic anticoagulation (INR 3.2) is an absolute contraindication.
Performing an LP with an INR of 3.2 poses a high risk of creating a spinal epidural hematoma that can cause permanent paralysis.
4
Evaluate the risks of modifying patient parameters (reversing anticoagulation) versus pursuing alternative testing.
Reversing anticoagulation is rejected due to the severe risk of thrombosis in her mechanical mitral valve.
Diagnostic procedures should utilize non-invasive alternatives before considering high-risk medication reversals.
5
Select the safest alternative diagnostic modality.
Computed tomography angiography (CTA) of the head is selected.
CTA is a rapid, non-invasive imaging study that can identify an intracranial aneurysm when LP cannot be safely performed.

Key Concept

Diagnostic sequencing for subarachnoid hemorrhage in patients with absolute contraindications to lumbar puncture.
Question 1454Question →

During a routine morning round on the telemetry unit, a hospitalized patient suddenly loses consciousness, and the central monitor instantly displays coarse ventricular fibrillation. No carotid pulse is palpable. Arrange the following emergency interventions in the correct chronological sequence according to standard Advanced Cardiac Life Support (ACLS) protocols for this specific presentation.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with immediate chest compressions, followed by early defibrillation, then epinephrine if the rhythm is refractory, and finally amiodarone for persistent ventricular fibrillation.
In the ACLS algorithm for ventricular fibrillation or pulseless ventricular tachycardia, immediate high-quality CPR is the foundational first step. As soon as a defibrillator is available, the patient should receive an electrical shock. If the shockable rhythm persists after another 2-minute cycle of CPR, epinephrine is administered. If the rhythm still does not convert after a subsequent shock, an antiarrhythmic such as amiodarone is given.

Step-by-Step Solution

1
Recognize cardiac arrest and immediately start CPR.
Maintains minimal coronary and cerebral perfusion.
Chest compressions are the fundamental first step in any pulseless patient while awaiting further equipment.
2
Perform electrical defibrillation.
Attempts to reset the electrical activity of the heart.
Ventricular fibrillation is a shockable rhythm, and early defibrillation is the only definitive treatment to restore an organized rhythm.
3
Administer epinephrine.
Causes peripheral vasoconstriction, increasing aortic diastolic pressure.
Given if the rhythm does not convert after the initial shock and subsequent CPR, to help improve perfusion during ongoing compressions.
4
Administer amiodarone.
Alters the myocardial action potential and refractory period.
Used as a second-line pharmacological agent when the patient remains in shock-refractory ventricular fibrillation despite early defibrillation and epinephrine.

Key Concept

Advanced Cardiac Life Support (ACLS) Pulseless Arrest Algorithm for Shockable Rhythms
Estimated Time:1m 0s
Question 1455Question →

Match each patient's clinical presentation and initial coagulation laboratory findings with the most appropriate next step in diagnostic test sequencing.

Click a left item, then click its matching right item

Items

A 34-year-old woman with unprovoked deep vein thrombosis and a history of recurrent miscarriages. Her isolated activated partial thromboplastin time (aPTT) is prolonged and fails to correct with a 1:1 mixing study.
A 65-year-old man with no prior bleeding history presents with sudden, severe muscle hematomas. His isolated aPTT is prolonged and fails to correct with a 1:1 mixing study.
A 72-year-old malnourished woman on prolonged broad-spectrum antibiotics presents with large ecchymoses. Both prothrombin time (PT) and aPTT are prolonged but completely correct with a 1:1 mixing study.
A 22-year-old woman with a lifelong history of epistaxis and heavy menses has normal PT, normal aPTT, and normal platelet count, but prolonged platelet function analyzer (PFA-100) closure time.

Matches

Show answer & explanation

Answer

Proper evaluation of abnormal coagulation parameters requires interpreting the 1:1 mixing study to differentiate between factor deficiencies (which correct) and inhibitors (which fail to correct), followed by selecting confirmatory tests based on the clinical phenotype of bleeding versus thrombosis.
Test sequencing for complex coagulation disorders strictly follows an algorithmic approach. The 1:1 mixing study is the pivotal branching point. If the mixing study corrects, the etiology is a deficiency (requiring factor assays or replacement trials like Vitamin K). If it fails to correct, an inhibitor is present, and the choice of the confirmatory test depends on whether the patient is experiencing bleeding (requiring a Bethesda assay for acquired hemophilia) or thrombosis (requiring dRVVT for antiphospholipid syndrome).

Step-by-Step Solution

1
Analyze the initial PT and aPTT results to identify the affected coagulation pathway.
Determines whether the defect lies in the intrinsic (aPTT), extrinsic (PT), or common (both) pathways.
This narrows the differential diagnosis to specific factors or inhibitors affecting those pathways.
2
Interpret the results of the 1:1 mixing study using normal plasma.
Correction indicates a factor deficiency; failure to correct indicates the presence of a circulating inhibitor.
Mixing normal plasma replaces missing factors but will be neutralized if an antibody/inhibitor is present.
3
Correlate the laboratory mechanism with the clinical presentation (hemorrhage vs. thrombosis).
Selects the highly specific confirmatory test (e.g., Bethesda assay for bleeding inhibitors, dRVVT for thrombotic inhibitors).
Different inhibitors have opposite clinical manifestations; lupus anticoagulants cause thrombosis in vivo despite prolonging aPTT in vitro.

Key Concept

Diagnostic sequencing of coagulation disorders using the 1:1 mixing study and clinical phenotype.
Estimated Time:2m 0s
Question 1456Question →

For each of the following patient scenarios, select the most appropriate initial diagnostic investigation from the available choices.

Click a left item, then click its matching right item

Items

A 65-year-old man experiencing acute tearing chest pain radiating to his back, severe hypertension, and unequal radial pulses.
A 30-year-old pregnant female at 10 weeks gestation evaluated for right lower quadrant abdominal pain, fever, and leukocytosis.
A 50-year-old female complaining of a sudden, maximally severe 'thunderclap' headache without focal neurologic deficits.
A 25-year-old male who noticed a painless, firm, and palpable mass in his right testicle during self-examination.

Matches

Show answer & explanation

Answer

The correct pairings align classic clinical presentations with their guideline-indicated first-line diagnostic tests: aortic dissection requires CT angiography, appendicitis in pregnancy requires abdominal ultrasound, subarachnoid hemorrhage requires non-contrast head CT, and a testicular mass requires a scrotal ultrasound.
Each pairing correctly aligns a classic, high-yield clinical syndrome with the single most appropriate, universally accepted initial diagnostic investigation recommended by current clinical guidelines.

Step-by-Step Solution

1
Analyze the first scenario (tearing chest pain and unequal pulses) to recognize suspected aortic dissection.
Identify CT angiography of the chest as the primary diagnostic modality for stable aortic dissection.
It provides rapid, definitive visualization of the intimal flap and extent of the dissection.
2
Analyze the second scenario (right lower quadrant pain in a pregnant patient) to recognize suspected appendicitis.
Identify graded compression abdominal ultrasound as the first step.
Imaging must prioritize fetal safety; ultrasound avoids the ionizing radiation associated with CT scans.
3
Analyze the third scenario (sudden 'thunderclap' headache) to recognize suspected subarachnoid hemorrhage.
Identify non-contrast CT of the head as the immediate next step.
Non-contrast CT is highly sensitive for acute blood in the subarachnoid space and avoids contrast, which can obscure hemorrhage.
4
Analyze the fourth scenario (painless, firm testicular mass) to recognize suspected testicular malignancy.
Identify scrotal ultrasound as the initial imaging test.
Ultrasound quickly and non-invasively determines whether a scrotal mass is intra- or extra-testicular, and solid or cystic.

Key Concept

Selection of the most appropriate initial diagnostic imaging modality based on the suspected clinical diagnosis and patient safety constraints.
Question 1457Question →

A 68-year-old man is brought to the emergency department by emergency medical services due to sudden-onset, severe shortness of breath. He has a history of ischemic cardiomyopathy with a known left ventricular ejection fraction of 25%25\%. Upon arrival, the patient is lethargic, diaphoretic, and using accessory muscles of respiration. His blood pressure is 72/4872/48 mm Hg, heart rate is 122122/min, respiratory rate is 3434/min, and oxygen saturation is 82%82\% on room air. Physical examination reveals cool, mottled extremities and prominent jugular venous distention. Auscultation of the lungs demonstrates coarse crackles in all lung fields. Which of the following is the most appropriate initial step in the stabilization of this patient?

Show answer & explanation

Answer: Endotracheal intubation

Answer

Endotracheal intubation is the most appropriate initial step to stabilize this patient's airway and breathing.
This patient is presenting with acute decompensated heart failure and cardiogenic shock, characterized by severe hypotension, cool and mottled extremities, and altered mental status. The initial stabilization of any critically ill patient must follow the ABCs (Airway, Breathing, Circulation). This patient is lethargic, hypoxic, and showing signs of impending respiratory failure (accessory muscle use, severe tachypnea). Endotracheal intubation is the most appropriate initial step to protect the airway, ensure adequate oxygenation, and decrease the work of breathing. Reducing the work of breathing is particularly critical in cardiogenic shock, as respiratory muscles can consume a massive amount of cardiac output during severe distress. Once the airway and breathing are secured, circulatory support (e.g., inotropes, vasopressors) can be safely initiated.

Step-by-Step Solution

1
Assess the patient's clinical presentation and vital signs.
The patient exhibits severe hypotension, hypoxia, lethargy, and signs of biventricular heart failure (crackles, jugular venous distention, mottled extremities).
To determine the severity of the patient's condition and identify life-threatening compromises.
2
Apply the principles of initial resuscitation (ABCs).
The patient has an unprotected airway (lethargy) and severe respiratory failure (hypoxia, tachypnea, accessory muscle use) in the setting of cardiogenic shock.
Airway and breathing must be secured before addressing circulation or initiating diagnostic workups.
3
Evaluate contraindications to noninvasive stabilization methods.
Noninvasive positive-pressure ventilation is contraindicated due to the patient's altered mental status and severe hypotension.
To select the safest and most definitive method of airway and ventilatory support.

Key Concept

In patients presenting with cardiogenic shock and acute pulmonary edema, definitive airway management (endotracheal intubation) takes precedence when there is altered mental status, severe hemodynamic instability, or impending respiratory failure.
Estimated Time:1m 15s
Question 1458Question →

A 32-year-old rock climber is brought to the emergency department by paramedics after an estimated 30-foot fall. He arrives immobilized on a backboard with a rigid cervical collar in place. He is agitated, tachycardic, and has an obvious deformity of his right femur. Arrange the following steps of his initial trauma resuscitation in the correct chronological order according to standard Advanced Trauma Life Support (ATLS) primary survey principles.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Airway assessment, followed by Breathing evaluation, Circulation management, Disability assessment, and finally Exposure.
The primary survey in trauma follows a strict chronological sequence to identify and treat conditions in order of immediate lethality: Airway with cervical spine protection, Breathing and ventilation, Circulation with hemorrhage control, Disability (neurologic status), and Exposure/environmental control.

Step-by-Step Solution

1
Identify the primary goal of initial trauma resuscitation.
The goal is to identify and treat life-threatening conditions in a systematic, prioritized manner based on immediate lethality.
Standardized protocols prevent distracting injuries from delaying care for immediately life-threatening airway or breathing compromise.
2
Apply the primary survey mnemonic to the provided steps.
The sequence follows A (Airway), B (Breathing), C (Circulation), D (Disability), and E (Exposure).
This algorithmic sequence is universally accepted for the initial stabilization of major trauma patients.
3
Map the specific clinical actions to the algorithmic sequence.
Airway patency (A) -> Breath sounds (B) -> Intravenous access (C) -> Glasgow Coma Scale (D) -> Undressing the patient (E).
Mapping the actions ensures the correct chronological order is established for patient safety.

Key Concept

Advanced Trauma Life Support (ATLS) Primary Survey Sequence (ABCDE)
Question 1459Question →

A 24-year-old female graduate student schedules an appointment at the university health clinic after noticing a lump in her right breast while showering. She reports that the lump has been present for approximately six weeks and has not fluctuated in size or tenderness with her menstrual cycles. Her medical history is unremarkable, and she takes no medications other than a combined oral contraceptive pill. Her family history is negative for breast or ovarian malignancies. Vital signs are within normal limits. On physical examination, there is a 2.5-cm, firm, highly mobile, non-tender, and well-circumscribed mass in the upper outer quadrant of the right breast. There is no overlying skin dimpling, nipple retraction, or palpable axillary lymphadenopathy. Which of the following is the most appropriate next step in the diagnostic evaluation of this patient?

Show answer & explanation

Answer: Targeted ultrasound of the right breast

Answer

Targeted ultrasound of the right breast
The correct answer is a targeted ultrasound of the right breast. In the diagnostic workup of a palpable breast mass, the patient's age dictates the initial imaging step. For patients under 30 years of age, targeted ultrasound is the modality of choice. This is because younger women typically have radiographically dense breast tissue, which obscures underlying lesions and significantly reduces the sensitivity of mammography. Furthermore, ultrasound is highly effective at differentiating benign fluid-filled cysts from solid masses (such as a fibroadenoma, which is the most likely diagnosis in this patient) and avoids exposing young tissue to ionizing radiation.

Step-by-Step Solution

1
Evaluate the patient's demographic profile and presenting symptom.
The patient is a 24-year-old female presenting with a new, solitary, palpable breast mass that is highly suspicious for a benign fibroadenoma based on its mobility and firm texture.
Age is the primary determining factor when selecting the initial imaging modality for a palpable breast mass.
2
Apply age-based clinical guidelines for breast imaging sequencing.
For women under 30 years of age, targeted ultrasound is the initial test of choice. For women 30 years and older, diagnostic mammography (often with ultrasound) is preferred.
Younger women possess radiographically dense breast tissue, which obscures underlying lesions and significantly lowers the sensitivity of mammography. Ultrasound avoids ionizing radiation while effectively differentiating solid from cystic masses.

Key Concept

In the diagnostic workup of a new palpable breast mass in a woman under 30 years of age, targeted ultrasound is the preferred initial imaging modality due to the high density of breast tissue in this age cohort.
Question 1460Question →

A 62-year-old man is evaluated in the intensive care unit for new-onset fever, increased purulent endotracheal secretions, and worsening oxygenation. He was intubated 6 days ago for severe blunt chest trauma following a motor vehicle collision. His medical history is significant for a severe, IgE-mediated anaphylactic allergy to penicillin, documented as causing diffuse urticaria, angioedema, and respiratory failure. Vital signs show a temperature of 39.2°C (102.6°F), heart rate of 122/min, and blood pressure of 82/45 mmHg despite the administration of 3 liters of intravenous crystalloid. He is started on a norepinephrine infusion. A chest radiograph reveals a new dense infiltrate in the right lower lobe. The patient requires prompt initiation of empiric antimicrobial therapy for suspected ventilator-associated pneumonia and septic shock. Which of the following antimicrobial agents should be included in this patient's empiric regimen? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Intravenous aztreonam; Intravenous ciprofloxacin; Intravenous linezolid

Answer

The appropriate empiric regimen for this patient includes intravenous aztreonam, intravenous ciprofloxacin, and intravenous linezolid.
The correct regimen for this patient includes intravenous aztreonam, ciprofloxacin, and linezolid. This patient has ventilator-associated pneumonia (VAP) complicated by septic shock. According to IDSA/ATS guidelines, patients with VAP and septic shock require empiric coverage for methicillin-resistant Staphylococcus aureus (MRSA) and two antipseudomonal agents from different classes to ensure adequate initial coverage and reduce mortality. Linezolid provides excellent MRSA coverage and strong lung penetration. For the required double antipseudomonal coverage in a patient with a severe, life-threatening IgE-mediated penicillin allergy, a monobactam like aztreonam is the agent of choice because it does not cross-react with other beta-lactams. A fluoroquinolone like ciprofloxacin is appropriate as the second antipseudomonal agent from a different class.

Step-by-Step Solution

1
Identify the clinical condition and severity.
The patient has ventilator-associated pneumonia (VAP) complicated by septic shock.
Establishing illness severity determines the breadth of empiric antimicrobial coverage required.
2
Determine the required antimicrobial spectrum according to guidelines.
The patient requires coverage for MRSA and double antipseudomonal coverage from different antibiotic classes.
IDSA/ATS guidelines recommend this broad three-drug approach for VAP patients presenting with septic shock due to the high risk of mortality and resistant organisms.
3
Select appropriate agents considering the patient's severe penicillin allergy.
Select linezolid for MRSA, aztreonam as the first antipseudomonal agent, and ciprofloxacin as the second antipseudomonal agent.
Aztreonam is the only safe cell-wall active antipseudomonal agent in severe penicillin anaphylaxis. Daptomycin cannot be used for pneumonia, and meropenem poses an allergy cross-reactivity risk.

Key Concept

Empiric treatment of ventilator-associated pneumonia (VAP) in patients with septic shock requires MRSA coverage and double antipseudomonal coverage; aztreonam is the beta-lactam of choice in severe penicillin allergy, and daptomycin is absolutely contraindicated for lung infections.
PreviousPage 73 / 104Next
Patient Management Practice Questions — USMLE Step 3 — Page 73 | Examkin